Elmiron (pentosan polysulfate sodium), a drug manufactured by Janssen Pharmaceuticals, is a medication often prescribed to treat interstitial cystitis (IC), a condition that affects the bladder, also known as Painful Bladder Syndrome. Most patients who are prescribed Elmiron are women over the age of 50 years old. Since there is no cure for IC, patients tend to take the medication long-term to relieve discomfort and pain.


Although some common side effects attributed to Elmiron tend to be mild, recently, there have been many reports of the medication causing a visual condition called maculopathy, as a result of the drug’s toxicity on the retina. Some symptoms of this ailment include blurred vision, difficulty adjusting to low lighting, and ability to see fine details.


Intake review: Verus reviews the information collected during intake to determine if additional information is needed. If so, Verus will contact the claimants and work with them to get the information necessary to complete their claim.

Medical records review: Verus’ can manage the acquisition of all necessary medical records which are then reviewed by a dedicated team for identification of the drug usage and the resulting effects and prepare reports and other work product to the law firms’ specifications.

Claimants’ communications: Verus will provide front-line support for communications with claimants through a dedicated toll-free phone number and a project-specific email address. Additionally, Verus can provide notice services for important written communications with claimants.

Plaintiff fact sheet preparation: Our team will conduct the medical record review and will also coordinate with claimants to complete plaintiff fact sheets.


Read our latest blog posts on Elmiron